Jan Kaiserle

Raw material imports for medicine currently account for $749 million in annual spending, representing more than half of the country's total medicinal foreign-exchange costs. This financial burden has catalyzed a strategic pivot toward domestic biotechnology, as the nation seeks to insulate its

The proposed six-level autonomy framework provides a shared technical vocabulary for engineers and regulators to navigate the gradual handoff of tasks from humans to machines. This strategy, unveiled at the Roche Pharma Day, establishes a rigorous pathway for the integration of robotics and

Modern drug discovery is shifting away from labor-intensive physical screening toward a hierarchical computational approach that merges machine learning with structural biology. This methodological evolution represents a major paradigm shift in oncology, where researchers at the Hangzhou Lin’an

While the COVID-19 pandemic accelerated the shift toward virtual care, the rapid growth of telehealth platforms has outpaced the federal regulations intended to protect sensitive patient data. For millions of Americans, the appeal of services like Hims & Hers, BetterHelp, and GoodRx lies in the

Market analysts predict that the rising cost of compliance will lead to a consolidation of healthcare vendors, leaving only those who can pass rigorous security audits. This projection follows the recent finalization of a massive $2.3 million multistate settlement involving the Wisconsin Department

Researchers at Birjand University of Medical Sciences are targeting the unique mechanical requirements of the knee by leveraging the dense native collagen found in camels. This specific focus on camel-derived tissue addresses one of the most persistent challenges in orthopedic medicine: the repair

Meaningful empowerment for clinical pharmacists requires more than rhetoric; it demands a systemic overhaul of workforce models and safe staffing levels. In the current landscape, the Australian hospital sector is facing a critical juncture where the complexity of medication management has outpaced

The shift by Cellectis to prioritize APOC3 and PCSK9 programs illustrates a broader movement toward genomic modulation for long-lasting treatment of chronic illnesses. This strategic pivot marks a departure from the industry’s early fixation on ultra-rare genetic disorders, signaling a newfound

Modern hydrogel designs mimic the natural environment of living tissue by maintaining a moisture content of roughly 90 percent to prevent cell death and scarring. This fundamental shift in wound management comes at a time when traditional methods are increasingly viewed as insufficient for the

The breach at McKesson highlights a shift in cybercrime tactics toward targeting the human firewall through deceptive phone calls and compromised single sign-on accounts. The cyberattack on McKesson Corporation, a giant in the North American pharmaceutical supply chain, has sent ripples through the